Category: News

Avalon Health Economics Collaborates with Acaster-LLoyd Consulting, Ltd.
December 26, 2018 - 12:36 pm, by
Avalon Health Economics is happy to announce an exciting new collaboration with the London-based Acaster-Lloyd Consulting, Ltd. Acaster-Lloyd, led by Sarah Acaster and Andrew Lloyd, is a leader in the area of clinical outcomes assessment (COA), including patient-reported outcomes, health-state utilities, strategy & analysis, preference surveys, instrument development, and qualitative research. The collaboration helps AHE...
Avalon Health Economics will be at ISPOR Barcelona, Nov. 10 through Nov. 14
September 28, 2018 - 11:31 am, by
Avalon Health Economics will be at ISPOR Barcelona, Nov. 10 through Nov. 14.  We will be engaged in our usual array of posters, podium presentations, and short courses.  If you are planning on attending, please let us know if you want to meet with any of our team!
Avalon will be attending AdvaMed in Philadelphia this September 24th-26th
May 9, 2018 - 9:52 am, by
Avalon will be attending AdvaMed in Philadelphia this September 24th-26th. To schedule meetings with the Avalon team, contact Nicole Nelson at nicole.nelson@avalonecon.com.
AHE Presents: Symposium on Emerging Trends in U.S. Health Economic Evaluation
February 1, 2018 - 12:16 pm, by
AHE Presents: Symposium on Emerging Trends in U.S. Health Economic Evaluation: A Closer Look at the Role of Cost Effectiveness in U.S. Market Access, Tuesday May 9th in Morristown, NJ
CEO John Schneider will be speaking at Research! America’s Medical Innovation 101 February briefing on Capitol Hill
January 6, 2018 - 12:14 pm, by
CEO John Schneider will be speaking at Research! America’s Medical Innovation 101 February briefing on Capitol Hill with Dr. Keith R. Yamamoto, Director of Precision Medicine at the University of California San Francisco, Dr. Joe V. Selby, Executive Director at PCORI, and others.
Avalon Health Economics will be attending ISPOR Vienna, October 29th-November 2nd
October 1, 2017 - 12:11 pm, by
John Schneider & Andrew Briggs will be teaching the Economics of Diagnostics Introduction Course on Sunday afternoon (1:00pm-5:00pm). Come say hi or sign up for the course! Let us know if you would like to schedule a time to meet in Vienna.
Analysis of Dental and Vision Plan Non-Covered Services and Materials Mandates and the Projected Role of H.R. 3323 in the Vision and Dental Markets
April 27, 2016 - 12:09 pm, by
Our research found that for doctors of optometry and dentists in both states, even after the enactment of laws barring NCS mandates, the vast majority of providers continued to offer normal discounts and receive payments from patients that were below their charged amounts. Thus, the laws had no effect on the providers—they continued billing their...
Avalon CEO John Schneider presented at BMO Capital Markets’ “The Year Ahead in Healthcare: Products, Payment and Politics” on December 15, 2015
December 29, 2015 - 12:08 pm, by
Avalon CEO John Schneider, Ph.D. presented at BMO Capital Markets’ “The Year Ahead in Healthcare: Products, Payment and Politics” on December 15, 2015. The day-long symposium was focused on markets for life science products and featured presentations from industry leaders, including Boston Scientific, Medtronic, Abbott and Pfizer. Schneider delivered a lunchtime presentation on the medical...
Philipp Schuetz joins Avalon Health Economics as a Clinical Director
November 27, 2015 - 12:07 pm, by
Avalon Health Economics is happy to announce the addition of Philipp Schuetz, MD, MPH as our Clinical Director. He is a board-certified internist and endocrinologist. He has broad clinical and research interests focusing on the application of new developments in endocrinology, infectious diseases, critical illness and general medicine. He has done extensive research on hormones,...
CEO John Schneider presents at Barclays HealthCare Symposium
November 23, 2015 - 12:05 pm, by
CEO John Schneider presented at the Barclays HealthCare Symposium on 11/20 on the topic of Increasing Need to Demonstrate Economic Value in Medtech.